QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 rbc-capital-reiterates-outperform-on-teleflex-maintains-260-price-target

RBC Capital analyst Shagun Singh reiterates Teleflex (NYSE:TFX) with a Outperform and maintains $260 price target.

 truist-securities-maintains-hold-on-teleflex-raises-price-target-to-247

Truist Securities analyst Richard Newitter maintains Teleflex (NYSE:TFX) with a Hold and raises the price target from $240 t...

 rbc-capital-maintains-outperform-on-teleflex-raises-price-target-to-260

RBC Capital analyst Shagun Singh maintains Teleflex (NYSE:TFX) with a Outperform and raises the price target from $235 to $260.

 stephens--co-maintains-overweight-on-teleflex-raises-price-target-to-290

Stephens & Co. analyst George Sellers maintains Teleflex (NYSE:TFX) with a Overweight and raises the price target from $...

Core News & Articles

Teleflex Incorporated (NYSE:TFX), a leading global provider of medical technologies, today announced it was awarded two group p...

 truist-securities-maintains-hold-on-teleflex-raises-price-target-to-240

Truist Securities analyst Richard Newitter maintains Teleflex (NYSE:TFX) with a Hold and raises the price target from $235 t...

 truist-securities-maintains-hold-on-teleflex-raises-price-target-to-235

Truist Securities analyst Richard Newitter maintains Teleflex (NYSE:TFX) with a Hold and raises the price target from $219 t...

 this-medical-devices-stock-has-several-catalysts-says-bullish-analyst

Teleflex gets an upgraded rating. Analyst Matt O'Brien takes it from Neutral to Overweight, and raises the price target fro...

 piper-sandler-upgrades-teleflex-to-overweight-raises-price-target-to-245

Piper Sandler analyst Matt O'Brien upgrades Teleflex (NYSE:TFX) from Neutral to Overweight and raises the price target f...

 fda-says-teleflexarrow-international-recall-arrow-fiberoptix-and-ultraflex-intra-aortic-balloon-catheter-kits-for-manufacturing-issue-as-class-i-recall-total-of-31-injuries--3-deaths-have-been-reported-potentially-related-to-manufacturing-issue

- Reuters

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION